Present Title & Affiliation

Primary Appointment

Bio Statement

I am a clinical investigator with a focus on developmental therapeutics and the use of biomarkers to predict response and recurrence in gynecologic cancers. My background in public health, with a focus on clinical investigation and epidemiology, has provided me with a clear understanding of the study design and validation techniques which are essential to the study of these topics. I am principal investigator of several novel treatment trials for endometrial cancer as well as a phase 1 trial of agents relevant to ovarian cancer.As part of the Stand Up to Cancer collaboration, I serve as the MD Anderson principal investigator for a trial of MK-2206, an AKT inhibitor, in recurrent endometrial cancer. This trial incorporates a novel biomarker-driven design, utilizing stratification by PIK3CA mutation status.